Treatment of choice for HIT syndrome –
**Heparin-Induced Thrombocytopenia (HIT) Syndrome**
### Core Concept
HIT syndrome is a serious immune-mediated disorder caused by the formation of antibodies against the complex of heparin and platelet factor 4 (PF4), leading to platelet activation, aggregation, and thrombocytopenia. This condition requires prompt treatment to prevent further thrombotic complications.
### Why the Correct Answer is Right
The treatment of choice for HIT syndrome is the discontinuation of heparin and the initiation of an alternative anticoagulant that does not cross-react with the anti-PF4 antibodies. The correct answer is fondaparinux, a synthetic anticoagulant that selectively inhibits factor Xa without the risk of cross-reactivity. Fondaparinux is a suitable alternative to heparin in patients with HIT syndrome, as it provides effective anticoagulation without the risk of exacerbating the condition.
### Why Each Wrong Option is Incorrect
**Option A:** Warfarin is not an appropriate initial treatment for HIT syndrome because it requires several days to achieve therapeutic anticoagulation and can actually worsen the condition by promoting the formation of new thrombi.
**Option B:** Aspirin is not effective as a sole treatment for HIT syndrome, as it does not provide adequate anticoagulation and can actually increase the risk of thrombosis.
### Clinical Pearl / High-Yield Fact
In patients with HIT syndrome, it is essential to discontinue heparin immediately and initiate an alternative anticoagulant to prevent further thrombotic complications. Fondaparinux is a suitable alternative, but other options such as argatroban or bivalirudin may also be used, depending on the clinical scenario and patient factors.
### Correct Answer: C.